Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Abstract

Background - Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, administration of the currently available vaccines has mostly been recommended for subjects at high risk, including elderly populations on long-term oral anticoagulation therapy (OAT) with warfarin. However, there is no clear evidence of the stability of the International Normalised Ratio (INR) after vaccine administration in those subjects on long-term OAT. The present study aimed to investigate the effects of COVID-19 vaccination on anticoagulation levels in patients on long-term OAT.
Materials and methods - INR values of patients on long-term OAT who had undergone anti-SARS-CoV-2 vaccination from January to June 2021 were monitored for a total of 90 days follow-up after the first vaccination dose. These were then compared with INR values before vaccination. The second dose, when required, was administered during follow-up. Inclusion criterion was stable long-term INR for at least 6 months before vaccination. Exclusion criteria were recent surgery, intercurrent diseases, or treatment with medication that could compromise findings in the 3 months before vaccination and during follow-up.
Results - No differences were observed in the anticoagulation levels before and after COVID-19 vaccination in any of the patients studied: mean INR values were 2.39 (range 2.20-2.63) before vaccination and 2.40 (range 2.16-2.76) after vaccination (p=0.5). There was no difference in anticoagulation levels in relation to age, sex, indication for OAT, or type of vaccine (p>0.5). No bleeding or thrombotic complications were documented during follow-up.
Discussion - These are the first data to be reported on anticoagulation levels in patients on stable OAT after COVID-19 vaccination. No influence on the quality of OAT was detected after the vaccination; no bleeding or thrombotic complications were recorded in the follow-up. No difference between the four available COVID vaccines was found. Dose adjustment was only required in a few cases, thus confirming the stability of anticoagulation levels.

References

Downloads

pdf
Authors

Elena Lotti Thrombosis Center University Hospital Careggi, Florence, Italy

Alessandro Masi Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Chiara Cappugi Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Alessandra Fanelli General Laboratory, University Hospital Careggi, Florence, Italy

Lucia Mannini Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Rossella Marcucci Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Daniela Poli Thrombosis Center University Hospital Careggi, Florence, Italy

  • Abstract viewed - 650 times
  • pdf downloaded - 0 times